 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - LA JOLLA PHARMACEUTICAL CO (LJPC)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-01-09 Purchase | 2020-01-13 5:59 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Director 10% Owner | 2,971,682 | $5.867 | $17,434,469 | 7,910,575 (Indirect) | View |
| 2020-01-14 Purchase | 2020-01-16 4:05 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 3,000 | $8.226 | $24,677 | 6,545 (Direct) | View |
| 2020-01-30 Purchase | 2020-02-03 5:02 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Director 10% Owner | 169,770 | $6.756 | $1,146,968 | 8,080,345 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-12-20 Option Award | 2019-12-23 4:09 pm | N/A 2029-12-20 | LA JOLLA PHARMACEUTICAL CO | LJPC | RAMSAY DAVID A Director | 12,000 | $3.93 | 12,000 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-23 4:10 pm | N/A 2029-12-20 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rosen Robert Director | 12,000 | $3.93 | 12,000 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-03 4:34 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 16 | $3.34 | 16 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-03 4:34 pm | N/A 2029-12-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 16 | $3.93 | 16 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-03 4:34 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 172 | $3.34 | 172 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-03 4:34 pm | N/A 2029-12-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 172 | $3.93 | 172 (Direct) | View |
| 2020-01-09 Option Award | 2020-01-13 4:17 pm | N/A 2030-01-09 | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 30,000 | $5.25 | 30,000 (Direct) | View |
| 2020-01-09 Option Award | 2020-01-13 4:17 pm | N/A 2030-01-09 | LA JOLLA PHARMACEUTICAL CO | LJPC | Johnson Craig A Director | 30,000 | $5.25 | 30,000 (Direct) | View |
| 2020-01-09 Option Award | 2020-01-13 4:18 pm | N/A 2030-01-09 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 30,000 | $5.25 | 30,000 (Direct) | View |
| 2020-01-09 Option Award | 2020-01-13 4:18 pm | N/A 2030-01-09 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 30,000 | $5.25 | 30,000 (Direct) | View |
| 2020-01-09 Option Award | 2020-01-13 4:19 pm | N/A 2030-01-09 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 30,000 | $5.25 | 30,000 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-17 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 692 | $6.7 | 692 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-17 4:13 pm | N/A 2030-01-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 692 | $7.88 | 692 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-17 4:14 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 498 | $6.7 | 498 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-17 4:14 pm | N/A 2030-01-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 498 | $7.88 | 498 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-17 4:14 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 1,188 | $6.7 | 1,188 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-17 4:14 pm | N/A 2030-01-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 1,188 | $7.88 | 1,188 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:01 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 282 | $5.82 | 282 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:01 pm | N/A 2030-01-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 282 | $6.85 | 282 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:01 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 141 | $5.82 | 141 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:01 pm | N/A 2030-01-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 141 | $6.85 | 141 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 101 | $5.82 | 101 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:02 pm | N/A 2030-01-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 101 | $6.85 | 101 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:47 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 115 | $7.14 | 115 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:47 pm | N/A 2030-02-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 115 | $8.4 | 115 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:48 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 83 | $7.14 | 83 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:48 pm | N/A 2030-02-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 83 | $8.4 | 83 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:48 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 229 | $7.14 | 229 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:48 pm | N/A 2030-02-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 229 | $8.4 | 229 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 284 | $5.78 | 284 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:13 pm | N/A 2030-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 284 | $6.8 | 284 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:14 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 102 | $5.78 | 102 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:14 pm | N/A 2030-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 102 | $6.8 | 102 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:14 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 142 | $5.78 | 142 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:14 pm | N/A 2030-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 142 | $6.8 | 142 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:12 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 173 | $3.4 | 173 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:12 pm | N/A 2030-03-13 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 173 | $4 | 173 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 483 | $3.4 | 483 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A 2030-03-13 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 483 | $4 | 483 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 241 | $3.4 | 241 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A 2030-03-13 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 241 | $4 | 241 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 229 | $3.57 | 229 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A 2030-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 229 | $4.2 | 229 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 459 | $3.57 | 459 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A 2030-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 459 | $4.2 | 459 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 165 | $3.57 | 165 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A 2030-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 165 | $4.2 | 165 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 146 | $5.61 | 146 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:02 pm | N/A 2030-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 146 | $6.6 | 146 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 350 | $5.61 | 350 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:02 pm | N/A 2030-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 350 | $6.6 | 350 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:03 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 34 | $5.61 | 34 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:03 pm | N/A 2030-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Wellinghoff Darryl Chief Commercial Officer | 34 | $6.6 | 34 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:03 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 58 | $5.61 | 58 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:03 pm | N/A 2030-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 58 | $6.6 | 58 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 53 | $6.17 | 53 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:08 pm | N/A 2030-04-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 53 | $7.26 | 53 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:09 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 319 | $6.17 | 319 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:09 pm | N/A 2030-04-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 319 | $7.26 | 319 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:09 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 133 | $6.17 | 133 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:09 pm | N/A 2030-04-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 133 | $7.26 | 133 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 140 | $5.86 | 140 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A 2030-05-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 140 | $6.89 | 140 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 335 | $5.86 | 335 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A 2030-05-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Chawla Lakhmir S Chief Medical Officer | 335 | $6.89 | 335 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 56 | $5.86 | 56 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A 2030-05-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | MULROY DENNIS CFO | 56 | $6.89 | 56 (Direct) | View |